Castle Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	63.76	116.73	119.71	98.84	122.95	329.63
Short-Term Investments	197.92	182.78	173.42	144.26	135.68	-
Cash & Short-Term Investments	261.69	299.51	293.13	243.1	258.63	329.63
Cash Growth	-4.89%	2.17%	20.58%	-6.00%	-21.54%	-19.57%
Accounts Receivable	42.26	43.38	51.22	38.3	23.48	17.28
Inventory	10.46	10.25	8.14	7.94	3.98	2.02
Other Current Assets	14.49	7.96	7.67	6.29	6.21	4.81
Total Current Assets	328.9	361.1	360.15	295.64	292.29	353.74
Net Property, Plant & Equipment	115.36	112.24	62.71	37.74	26.5	16.88
Goodwill	97.35	99.57	106.23	117.34	126.35	88.92
Other Long-Term Assets	6.2	5.65	2.15	2.63	2.2	3.02
Total Assets	547.81	578.56	531.24	453.34	447.33	462.57
Accounts Payable	15.04	18.71	6.9	10.27	4.73	2.55
Accrued Expenses	29.8	47.22	40.55	36.26	29.62	21.16
Current Portion of Long-Term Debt	1.67	0.42	0.28	-	-	-
Current Portion of Leases	1.25	1.33	1.67	1.14	1.78	1.18
Other Current Liabilities	1	1	-	-	-	-
Total Current Liabilities	48.76	68.68	49.39	47.67	36.13	24.89
Long-Term Debt	8.4	9.64	9.75	-	-	-
Long-Term Leases	25.4	25.53	14.66	14.2	11.53	6.9
Other Long-Term Liabilities	3.83	3.84	1.61	0.21	0.52	19.05
Total Long-Term Liabilities	37.63	39.01	26.01	14.4	12.05	25.95
Total Liabilities	86.39	107.68	75.4	62.07	48.18	50.83
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-in Capital	700.26	694.86	655.7	609.48	560.41	505.48
Accumulated Other Comprehensive Income	-0.06	0.27	0.23	0.14	-0.38	-
Retained Earnings	-238.81	-224.28	-200.13	-218.37	-160.91	-93.77
Shareholders' Equity	461.42	470.87	455.84	391.27	399.15	411.74
Total Liabilities & Equity	547.81	578.56	531.24	453.34	447.33	462.57
Total Debt	36.72	36.91	26.34	15.34	13.31	8.08
Net Cash (Debt)	224.96	262.59	266.79	227.76	245.32	321.55
Net Cash Growth	-14.33%	-1.57%	17.13%	-7.15%	-23.71%	-20.95%
Net Cash Per Share	7.64	9.06	9.12	8.50	9.42	12.79
Book Value	461.42	470.87	455.84	391.27	399.15	411.74
Book Value Per Share	15.66	16.24	15.58	14.60	15.32	16.38
Tangible Book Value	364.07	371.3	349.61	273.93	272.8	322.82
Tangible Book Value Per Share	12.36	12.81	11.95	10.22	10.47	12.84

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q